What does Donald Trump’s former commerce secretary Wilbur Ross mean when he says in Dublin that pharmaceutical companies “gradually come around”? The answer, if correct, is reassuring for Ireland.
The Federal Reserve’s reputation for independence is more illusion than fact. From its origins tied to the Treasury to its modern role in inflating asset bubbles, the Fed has long served political and financial interests — leaving Wall Street unfazed by Trump’s latest assault on its leadership.
The Irish packaging giant is one of several firms accused in a complaint by a pastry business of anti-competitive actions and coordinated price increases.
Another week, another tariff deadline extension. There is every indication that the negotiations between the US and the EU are far from being over.
The Maga movement that swept Donal Trump to victory has been seriously splintered by the Epstein sex storm. The scandal has engulfed the Republican party and emboldened the Democrats, writes Siobhán Brett in the US.
How should a pharma multinational respond to the uncertainty unleashed by the Trump administration? Invest more in Ireland, the contact-lens and eye-drop giant appears to have decided.
US firms show no sign of retreating from Ireland as Washington makes the temporary tax advantages introduced by Trump in 2017 permanent. Corporation tax is now set for another record year.
Eighty years after the publication of his breakthrough novel Animal Farm, the writer’s dissection of the drift towards authoritarianism remains as relevant as ever – despite deep personal contradictions.
Fiscal policies and inflation have changed the way investors consider long-term government debt. Who wins?
Rather than a decoupling from the fortunes of US multinationals, the volatility reported by the Exchequer last month shows Ireland is more exposed to them than ever.
© 2025 Currency Media Limited
